Gene · 7072
Papers4,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons. | Nat Commun | 2022 | 36357392 | PubTator, text mining | PubMed |
| Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products. | J Transl Med | 2022 | 36348415 | PubTator, text mining | PubMed |
| Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia. | Orphanet J Rare Dis | 2022 | 36345033 | PubTator, text mining | PubMed |
| hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target. | Front Pharmacol | 2022 | 36339596 | PubTator, text mining | PubMed |
Whole-slide image analysis identifies a high content of Hodgkin Reed-Sternberg cells and a low content of T lymphocytes in tumor microenvironment as predictors of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD. | Front Oncol | 2022 | 36338756 | PubTator, text mining | PubMed |
| Stress granules dynamics: benefits in cancer. | BMB Rep | 2022 | 36330685 | PubTator, text mining | PubMed |
| [Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma]. | Hinyokika Kiyo | 2022 | 36329378 | PubTator, text mining | PubMed |
| Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation. | Aging (Albany NY) | 2022 | 36326691 | PubTator, text mining | PubMed |
| Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sites. | RNA | 2022 | 36316087 | PubTator, text mining | PubMed |
| Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1-related spectrum. | Ann Clin Transl Neurol | 2022 | 36314424 | PubTator, text mining | PubMed |
| Reorganization of Cell Compartmentalization Induced by Stress. | Biomolecules | 2022 | 36291650 | PubTator, text mining | PubMed |
| Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein-Barr virus infection: A case-based review. | Front Immunol | 2022 | 36275709 | PubTator, text mining | PubMed |
| ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review. | Onco Targets Ther | 2022 | 36267610 | PubTator, text mining | PubMed |
| Tau interactome and RNA binding proteins in neurodegenerative diseases. | Mol Neurodegener | 2022 | 36253823 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia. | Oxid Med Cell Longev | 2022 | 36246407 | PubTator, text mining | PubMed |
| A sePARate phase? Poly(ADP-ribose) versus RNA in the organization of biomolecular condensates. | Nucleic Acids Res | 2022 | 36243979 | PubTator, text mining | PubMed |
| Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation. | Front Oncol | 2022 | 36237332 | PubTator, text mining | PubMed |
| Mitochondrion-Mediated Cell Death through Erk1-Alox5 Independent of Caspase-9 Signaling. | Cells | 2022 | 36231015 | PubTator, text mining | PubMed |
| Liquid-Liquid Phase Separation of Biomacromolecules and Its Roles in Metabolic Diseases. | Cells | 2022 | 36230986 | PubTator, text mining | PubMed |
| CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer/T-Cell Lymphoma Progression. | Cancers (Basel) | 2022 | 36230873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7072/papers?page=30